Tocotrienol as a Nutritional Supplement in Patients With Advanced Lung Cancer
Status:
Terminated
Trial end date:
2021-01-15
Target enrollment:
Participant gender:
Summary
There is a need for improving the effect of first-line chemotherapy for lung cancer patients,
preferably by using an approach with none or very few side effects.
In this trial the investigators incorporate δ-tocotrienol/placebo as a nutritional supplement
on top of standard chemotherapy for patients with advanced non-small cell lung cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Vejle Hospital
Treatments:
Carboplatin Cisplatin Tocopherols Tocotrienols Vinblastine Vinorelbine Vitamin E